Free Trial
TSE:INO

Inovalis Real Estate Investment Trust (INO) Stock Price, News & Analysis

Inovalis Real Estate Investment Trust logo

About Inovalis Real Estate Investment Trust Stock (TSE:INO)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, such as head and neck, cervical, anal, penile, vulvar, and vaginal; other HPV-associated disorders, including recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East Respiratory Syndrome (MERS); and Lassa fever. Its partners and collaborators include ApolloBio Corp., AstraZeneca, Beijing Advaccine Biotechnology Co., Ltd., The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA), Department of Defense (DoD), HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. The company has an agreement with Richter-Helm BioLogics GmbH & Co. KG to support investigational DNA vaccine INO-4800 for COVID-19; and a partnership with International Vaccine Institute and Seoul National University Hospital. The company was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.

Remove Ads
Receive INO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inovalis Real Estate Investment Trust and its competitors with MarketBeat's FREE daily newsletter.

INO Stock News Headlines

What is Desjardins' Estimate for TSE:INO FY2025 Earnings?
What is Desjardins' Estimate for TSE:INO Q1 Earnings?
**Breaking NEWS* This Company Starts To Rally As it Reduces $20 Million in Debt
**Breaking NEWS* This Company Starts To Rally As it Reduces $20 Million in Debt Discover why Notable Names like Cisco, Hewlett Packard and New York Life are Choosing to Do Business with this Growing Marketing Tech Company
Stocks in play: Inovalis Real Estate Investment Trust
See More Headlines

INO Stock Analysis - Frequently Asked Questions

Shares of INO stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Inovalis Real Estate Investment Trust investors own include Artis REIT (AX), Walt Disney (DIS), Dynavax Technologies (DVAX), Harpoon Therapeutics (HARP), Moderna (MRNA), Pfizer (PFE) and TransAlta Renewables (RNW).

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Surgical, Medical, And Dental Instruments And Supplies
Sub-Industry
Medical Equipment
Current Symbol
TSE:INO
CIK
N/A
Web
N/A
Fax
N/A
Employees
320
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (TSE:INO) was last updated on 4/8/2025 by MarketBeat.com Staff
From Our Partners